0 By Dr Donald Poon In CancerPosted September 15, 2021Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor READ MORE